What is a stock summary page? Click here for an overview.
Business Description
Akeso Inc
NAICS : 541713
SIC : 2833
ISIN : KYG0146B1032
Share Class Description:
AKESF: Ordinary SharesCompare
Compare
Traded in other countries / regions
09926.Hong KongAKESF.USA4RY.Germany IPO Date
2021-09-03Description
Akeso Inc is an investment holding company. The Company's subsidiaries were involved in research and development, production, and commercialization of biopharmaceutical products. The company currently has a pipeline of over 30 drugs for the treatment of diseases like cancers, autoimmune diseases, inflammation, and metabolic diseases, 17 of which have entered the clinical stage, including two first-in-class bi-specific antibody drugs (PD-1/CTLA-4 and PD-1/VEGF). The majority of the company's revenue is earned in USA.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.86 | |||||
| Equity-to-Asset | 0.53 | |||||
| Debt-to-Equity | 0.58 | |||||
| Debt-to-EBITDA | -11.46 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 7.93 | |||||
| Beneish M-Score | -0.15 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 98.8 | |||||
| 3-Year EBITDA Growth Rate | 32.7 | |||||
| 3-Year EPS without NRI Growth Rate | 25.4 | |||||
| 3-Year FCF Growth Rate | 36.4 | |||||
| 3-Year Book Growth Rate | 19.6 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 54.25 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 29.48 | |||||
| 9-Day RSI | 38.17 | |||||
| 14-Day RSI | 42.68 | |||||
| 3-1 Month Momentum % | 33.1 | |||||
| 6-1 Month Momentum % | -2.92 | |||||
| 12-1 Month Momentum % | 50.78 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.15 | |||||
| Quick Ratio | 4.73 | |||||
| Cash Ratio | 4.35 | |||||
| Days Inventory | 677.17 | |||||
| Days Sales Outstanding | 73.88 | |||||
| Days Payable | 500.15 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.2 | |||||
| Shareholder Yield % | -1.13 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 86.41 | |||||
| Operating Margin % | -23.72 | |||||
| Net Margin % | -24.22 | |||||
| FCF Margin % | -36.57 | |||||
| ROE % | -9.17 | |||||
| ROA % | -4.74 | |||||
| ROIC % | -10.09 | |||||
| 3-Year ROIIC % | 35.8 | |||||
| ROC (Joel Greenblatt) % | -10.62 | |||||
| ROCE % | -4.6 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 546.4 | |||||
| PS Ratio | 27.13 | |||||
| PB Ratio | 8.92 | |||||
| Price-to-Tangible-Book | 9.01 | |||||
| EV-to-EBIT | -117.6 | |||||
| EV-to-Forward-EBIT | -171.74 | |||||
| EV-to-EBITDA | -148.04 | |||||
| EV-to-Forward-EBITDA | 315.53 | |||||
| EV-to-Revenue | 23.96 | |||||
| EV-to-Forward-Revenue | 15.02 | |||||
| EV-to-FCF | -88.04 | |||||
| Price-to-GF-Value | 0.67 | |||||
| Price-to-Net-Current-Asset-Value | 22.42 | |||||
| Price-to-Net-Cash | 43.71 | |||||
| Earnings Yield (Greenblatt) % | -0.85 | |||||
| FCF Yield % | -1.36 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:AKESF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Akeso Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 292.226 | ||
| EPS (TTM) ($) | -0.083 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 79.58 | ||
| 14-Day RSI | 42.68 | ||
| 14-Day ATR ($) | 0.711175 | ||
| 20-Day SMA ($) | 9.374585 | ||
| 12-1 Month Momentum % | 50.78 | ||
| 52-Week Range ($) | 4.3 - 11.904 | ||
| Shares Outstanding (Mil) | 897.56 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Akeso Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Akeso Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Akeso Inc Frequently Asked Questions
What is Akeso Inc(AKESF)'s stock price today?
The current price of AKESF is $8.74. The 52 week high of AKESF is $11.90 and 52 week low is $4.30.
When is next earnings date of Akeso Inc(AKESF)?
The next earnings date of Akeso Inc(AKESF) is 2025-08-28 Est..
Does Akeso Inc(AKESF) pay dividends? If so, how much?
Akeso Inc(AKESF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers